Monotherapy for hepatitis B infection: a review of treatment options.

about

Monotherapy for hepatitis B infection: a review of treatment options.

Item

http://www.wikidata.org/entity/Q38594605

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Monotherapy for hepatitis B infection: a review of treatment options.

@en

type

Item

label

Monotherapy for hepatitis B infection: a review of treatment options.

@en

prefLabel

Monotherapy for hepatitis B infection: a review of treatment options.

@en

P1476

Monotherapy for hepatitis B infection: a review of treatment options.

@en

P2093

Burak Isal

http://www.w3.org/2001/XMLSchema#string

Goknil Gultekin

http://www.w3.org/2001/XMLSchema#string

Hawa'a Khodor

http://www.w3.org/2001/XMLSchema#string

Nergul Yetim

http://www.w3.org/2001/XMLSchema#string

Resat Ozaras

http://www.w3.org/2001/XMLSchema#string

Umut Kaan Unal

http://www.w3.org/2001/XMLSchema#string

Yunus Emre Demirhan

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

Telbivudine versus lamivudine in patients with chronic hepatitis B

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Chronic hepatitis B: update 2009

The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation.

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy.

Trends in waiting list registration for liver transplantation for viral hepatitis in the United States.

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.

Interferon for hepatitis B: US experience

P304

1457-1468

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14787210.2015.1093934

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26414781

http://www.w3.org/2001/XMLSchema#string